RHYTHM PHARMACEUTICALS, INC. Income Statement
RYTM / Health Care|11 years of annual SEC 10-K data (FY2015-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 11 fiscal years. All figures from audited SEC 10-K filings.
RHYTHM PHARMACEUTICALS, INC. reported $190M in revenue and $197M in net loss for FY2025. Revenue has grown at a 178.5% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $189.8M | $130.1M | $77.4M | $23.6M | $3.2M | - | - | $0 | $0 | $0 | - |
| Cost of Revenue | $19.5M | $13.4M | $9.3M | $2.1M | $599.0K | - | - | - | - | - | - |
| SG&A Expense | $194.9M | $144.3M | $117.5M | $92.0M | $68.5M | $46.1M | $36.5M | $28.1M | $9.5M | $6.3M | $3.4M |
| R&D Expense | $167.3M | $238.0M | $135.0M | $108.6M | $104.1M | $90.5M | $109.5M | $50.3M | $22.9M | $19.6M | $7.1M |
| Operating Income | -$192.0M | -$265.5M | -$184.4M | -$179.2M | -$170.1M | -$136.6M | -$146.0M | -$78.4M | -$32.4M | -$25.9M | -$10.6M |
| Interest Expense | - | - | $13.9M | $5.2M | - | - | - | - | - | - | - |
| Income Tax | $497.0K | $346.0K | $564.0K | - | - | - | - | - | - | - | - |
| Net Income | -$196.5M | -$260.6M | -$184.7M | -$181.1M | -$69.6M | -$134.0M | -$140.7M | -$74.1M | -$33.7M | -$25.9M | -$11.1M |
| EPS (Basic) | -$3.20 | -$3.47 | -$1.40 | -$3.47 | -$1.40 | -$3.04 | -$3.86 | - | - | - | - |
| EPS (Diluted) | -$3.20 | -$3.20 | -$1.40 | -$3.47 | -$1.40 | -$3.04 | -$3.86 | -$2.85 | -$1.18 | - | - |
| Shares Outstanding | 62.4M | 59.4M | 56.6M | 52.1M | 49.6M | 44.1M | 36.4M | 27.3M | 10.2M | 10.2M | 10.2M |
| Operating Margin | -101.2% | -204.0% | -238.1% | - | - | - | - | - | - | - | - |
| Profit Margin | -103.6% | -200.3% | -238.5% | - | - | - | - | - | - | - | - |